Medicine
Anastrozole 1 mg tablet
Anastrozole 1 mg tablet is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Anastrozole
- Brand
- Sold under the generic name
- Strength
- 1 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1000 tablets, 90 tablets and 102 more
- Manufacturers
- Zydus LifesciencesIndiaAccord HealthcareIndiaAvet PharmaceuticalsIndiaAurobindo PharmaIndiaNatco PharmaIndiaNuCare Pharmaceuticals,IncBreckenridge PharmaceuticalChartwell RXUpsher-Smith LaboratoriesYiling Pharmaceutical21 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BG03 Anastrozole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 June 2010
- Identifiers
- RxCUI 199224DailyMed set ID aabd8f88-2b52-4d43-8dc6-61605988c4dc, dface914-5135-4136-82f4-75429b496a35, 965c4cb1-f6b8-47ac-bf13-c36639aa908f +37NDC 72789-008, 60687-112, 65841-743 +37Application ANDA090568, ANDA078921, ANDA079220 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 21 labelers. The register lists 105 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, coated in 1 bottle | 65841-743-06 | Zydus LifesciencesIndia | 27 June 2010 |
| 1000 tablet, coated in 1 bottle | 65841-743-10 | Zydus LifesciencesIndia | 27 June 2010 |
| 30 tablet, coated in 1 bottle | 68382-209-06 | Zydus LifesciencesIndia | 27 June 2010 |
| 1000 tablet, coated in 1 bottle | 68382-209-10 | Zydus LifesciencesIndia | 27 June 2010 |
| 30 tablet in 1 bottle, plastic | 16729-035-10 | Accord HealthcareIndia | 22 June 2010 |
| 90 tablet in 1 bottle, plastic | 16729-035-15 | Accord HealthcareIndia | 24 February 2011 |
| 500 tablet in 1 bottle, plastic | 16729-035-16 | Accord HealthcareIndia | 21 March 2011 |
| 30 tablet, film coated in 1 bottle | 59651-236-30 | Aurobindo PharmaIndia | 24 July 2020 |
| 90 tablet, film coated in 1 bottle | 59651-236-90 | Aurobindo PharmaIndia | 24 July 2020 |
| 30 tablet in 1 bottle | 23155-857-03 | Avet PharmaceuticalsIndia | 28 February 2019 |
| 500 tablet in 1 bottle | 23155-857-05 | Avet PharmaceuticalsIndia | 28 February 2019 |
| 90 tablet in 1 bottle | 23155-857-09 | Avet PharmaceuticalsIndia | 28 February 2019 |
| 30 tablet in 1 bottle | 63850-0010-1 | Natco PharmaIndia | 28 June 2010 |
| 1000 tablet in 1 bottle | 63850-0010-2 | Natco PharmaIndia | 28 June 2010 |
| 1000 tablet in 1 bottle | 51991-620-10 | Breckenridge Pharmaceutical | 28 June 2010 |
| 30 tablet in 1 bottle | 51991-620-33 | Breckenridge Pharmaceutical | 28 June 2010 |
| 90 tablet in 1 bottle | 51991-620-90 | Breckenridge Pharmaceutical | 1 April 2023 |
| 30 tablet in 1 bottle | 62135-490-30 | Chartwell RX | 17 January 2022 |
| 90 tablet in 1 bottle | 62135-490-90 | Chartwell RX | 17 January 2022 |
| 30 tablet, film coated in 1 bottle | 0093-7536-56 | Teva Pharmaceuticals | 28 June 2010 |
| 30 tablet in 1 bottle | 24979-725-06 | Upsher-Smith Laboratories | 21 March 2025 |
| 90 tablet in 1 bottle | 24979-725-07 | Upsher-Smith Laboratories | 21 March 2025 |
| 30 tablet in 1 bottle | 69117-0003-1 | Yiling Pharmaceutical | 28 February 2019 |
| 1000 tablet in 1 bottle | 69117-0003-4 | Yiling Pharmaceutical | 28 February 2019 |
| 90 tablet in 1 bottle, plastic | 68071-1543-9 | NuCare Pharmaceuticals,Inc | 9 December 2022 |
| 30 tablet in 1 bottle | 68071-1682-3 | NuCare Pharmaceuticals,Inc | 27 September 2017 |
| 8 tablet in 1 bottle, plastic | 68071-2791-0 | NuCare Pharmaceuticals,Inc | 17 March 2025 |
| 20 tablet in 1 bottle, plastic | 68071-2791-2 | NuCare Pharmaceuticals,Inc | 13 July 2022 |
| 15 tablet in 1 bottle, plastic | 68071-2791-5 | NuCare Pharmaceuticals,Inc | 13 July 2022 |
| 12 tablet in 1 bottle, plastic | 68071-2791-7 | NuCare Pharmaceuticals,Inc | 3 January 2025 |
| 180 tablet in 1 bottle, plastic | 68071-2791-8 | NuCare Pharmaceuticals,Inc | 13 July 2022 |
| 90 tablet in 1 bottle | 68071-3838-9 | NuCare Pharmaceuticals,Inc | 29 April 2025 |
| 15 tablet in 1 bottle | 68071-3853-5 | NuCare Pharmaceuticals | 29 September 2026 |
| 12 tablet in 1 bottle | 68071-3853-7 | NuCare Pharmaceuticals | 9 December 2025 |
| 8 tablet in 1 bottle | 68071-3853-8 | NuCare Pharmaceuticals | 27 May 2025 |
| 30 tablet in 1 bottle | 68071-3999-3 | NuCare Pharmaceuticals | 7 May 2026 |
| 30 tablet in 1 bottle | 68071-4038-3 | NuCare Pharmaceuticals,Inc | 13 April 2018 |
| 30 tablet in 1 bottle | 68071-5203-3 | NuCare Pharmaceuticals,Inc | 12 March 2020 |
| 30 tablet in 1 bottle | 68071-5329-3 | NuCare Pharmaceuticals | 8 October 2026 |
| 6 tablet in 1 bottle, plastic | 43063-383-06 | PD-Rx Pharmaceuticals | 23 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 December 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Anastrozole 1 mg tablet.
Clinical summary
Anastrozole is an aromatase inhibitor indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Anastrozole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AnastrozoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ARIMIDEX prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Anastrozole 1 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.